Neocannbio Co., Ltd has been selected as one of 51 'baby unicorn' companies with high potential to grow into global unicorns (privately held companies with an enterprise value of KRW 1 trillion or more). As a result of this selection, Neocannbio will receive up to 300 million won in 'New Market Development Fund' and will be eligible to apply for up to 5 billion won in special guarantees, up to 10 billion won in policy funds, and up to 2 billion won in R&D funds.